Heart Matters Program for Cardiovascular Disease
(Co-LEARN Trial)
Trial Summary
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the Heart Matters Program treatment for cardiovascular disease?
The effectiveness of the Heart Matters Program for cardiovascular disease may be supported by similar programs that focus on outcomes management, which have shown improved patient outcomes in heart failure and coronary artery disease by regularly measuring and providing feedback on patient progress.12345
What makes the Heart Matters Program treatment unique for cardiovascular disease?
The Heart Matters Program is unique because it focuses on a multidisciplinary, behavior-oriented approach that includes lifestyle changes like diet and exercise, similar to the Heart Smart Program, which has shown positive results in reducing cardiovascular risk factors in families. This program is adaptable to clinical practice and emphasizes active communication between patients and health professionals to improve health outcomes.678910
What is the purpose of this trial?
The goal of this non-randomized, propensity-matched-controlled study is to assess the effectiveness of the Heart Matters evidence-based program -- previously evaluated for feasibility and efficacy in NCT02707432 -- in improving cardiovascular health outcomes (change in systolic and diastolic blood pressure, primary outcomes) when implemented by community-based facilitators.
Research Team
Gaurav Dave, MBBS, DrPH
Principal Investigator
University of North Carolina, Chapel Hill
Eligibility Criteria
This trial is for individuals with cardiovascular disease living in rural areas. Participants should be interested in improving their heart health and willing to work with community-based facilitators.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Heart Matters intervention delivered by community-based facilitators
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Heart Matters
Heart Matters is already approved in United States for the following indications:
- Cardiovascular health improvement
- Hypertension management
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
James McFarlin Community Development, Inc.
Collaborator
Opportunities Industrialization Center, Inc.
Collaborator
Project Momentum, Inc.
Industry Sponsor
James McFarlin Community Development, Inc.
Collaborator